[Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE